Viewing Study NCT02958969


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2026-02-11 @ 8:34 PM
Study NCT ID: NCT02958969
Status: COMPLETED
Last Update Posted: 2019-12-17
First Post: 2016-11-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
Sponsor: Gregory Piazza
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 18-493
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View